日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Metallothionein 1: the Achilles heel of Dnmt3a;Npm1-mutant acute myeloid leukemia

金属硫蛋白 1:Dnmt3a;Npm1 突变型急性髓系白血病的阿喀琉斯之踵

Yan, Bowen; Guryanova, Olga A

Clonal hematopoiesis driven by Dnmt3a mutations promotes metabolic disease development in mice

由Dnmt3a突变驱动的克隆性造血促进小鼠代谢性疾病的发生发展。

Yan, Bowen; Yuan, Qingchen; Buttigieg, Marco M; Kaur, Prabhjot; McKee, Annalisse R; Shabashvili, Daniil E; Vlasschaert, Caitlyn; Bick, Alexander G; Rauh, Michael J; Guryanova, Olga A

Multifaceted Marine Peptides and Their Therapeutic Potential

多功能海洋肽及其治疗潜力

Guryanova, Svetlana V; Ovchinnikova, Tatiana V

Transcription Factors and Methods for the Pharmacological Correction of Their Activity

转录因子及其活性药理学调控方法

Guryanova, Svetlana V; Maksimova, Tatiana V; Azova, Madina M

DR5 Disulfide Bonding Functions as a Sensor and Effector of Protein Folding Stress

DR5二硫键作为蛋白质折叠应激的传感器和效应器发挥作用

Mary E Law # ,Zaafir M Dulloo # ,Samantha R Eggleston ,Gregory P Takacs ,Grace M Alexandrow ,Young Il Lee ,Mengxiong Wang ,Brian Hardy ,Hanyu Su ,Bianca Forsyth ,Parag Das ,Pran K Datta ,Chi-Wu Chiang ,Abhisheak Sharma ,Siva Rama Raju Kanumuri ,Olga A Guryanova ,Jeffrey K Harrison ,Boaz Tirosh ,Ronald K Castellano ,Brian K Law

CerS2 is a druggable target in triple-negative breast cancer.

CerS2 是三阴性乳腺癌的一个可药物靶点

Alatawi Hissah, Nair Haritha H, Ai Lingbao, Mahmud Iqbal, Gour Abhishek, Singh Amandeep, Baek Doohyun, Yan Bowen, Maharjan Chandra K, Zhang Weizhou, Law Brian K, Zajac-Kaye Maria, Vulpe Christopher, Guryanova Olga A, Sharma Arun K, Garrett Timothy J, Sharma Abhisheak, Heldermon Coy D, Hong Sukwon, Narayan Satya

Overcoming ABCB1 mediated multidrug resistance in castration resistant prostate cancer

克服去势抵抗性前列腺癌中 ABCB1 介导的多药耐药性

Sadia Sarwar #, Viacheslav M Morozov #, Mallory A Newcomb, Bowen Yan, Jason O Brant, Rene Opavsky, Olga A Guryanova, Alexander M Ishov

Decoding the identity of rare tumors

解读罕见肿瘤的身份

Yuan, Qingchen; Kaur, Prabhjot; Guryanova, Olga A

Biomarkers of success of anti-PD-(L)1 immunotherapy for non-small cell lung cancer derived from RNA- and whole-exome sequencing: results of a prospective observational study on a cohort of 85 patients

基于RNA和全外显子组测序的非小细胞肺癌抗PD-(L)1免疫疗法疗效生物标志物:一项纳入85例患者的前瞻性观察性研究结果

Poddubskaya, Elena; Suntsova, Maria; Lyadova, Marina; Luppov, Daniil; Guryanova, Anastasia; Lyadov, Vladimir; Garazha, Andrew; Sorokin, Maksim; Semenova, Anna; Shatalov, Vitaly; Biakhova, Maria; Simonov, Alexander; Moisseev, Aleksey; Buzdin, Anton

Bacteria and Allergic Diseases

细菌与过敏性疾病

Guryanova, Svetlana V